Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5273830
Max Phase: Preclinical
Molecular Formula: C23H21N5O2S
Molecular Weight: 431.52
Associated Items:
ID: ALA5273830
Max Phase: Preclinical
Molecular Formula: C23H21N5O2S
Molecular Weight: 431.52
Associated Items:
Canonical SMILES: CCc1ccccc1-n1nc(-c2c[nH]c3ccc(OC)cc23)cc1/N=C1/NC(=O)CS1
Standard InChI: InChI=1S/C23H21N5O2S/c1-3-14-6-4-5-7-20(14)28-21(25-23-26-22(29)13-31-23)11-19(27-28)17-12-24-18-9-8-15(30-2)10-16(17)18/h4-12,24H,3,13H2,1-2H3,(H,25,26,29)
Standard InChI Key: PUKJNXRPGMKZGU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 431.52 | Molecular Weight (Monoisotopic): 431.1416 | AlogP: 4.44 | #Rotatable Bonds: 5 |
Polar Surface Area: 84.30 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.57 | CX Basic pKa: 0.94 | CX LogP: 4.89 | CX LogD: 4.67 |
Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.49 | Np Likeness Score: -0.88 |
1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N.. (2023) Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors., 14 (3): [PMID:36970141] [10.1039/d2md00442a] |
Source(1):